Non-steroidal anti-inflammatory drugs (NSAIDs) for musculoskeletal pain
BMJ
.
2021 Jan 29:372:n104.
doi: 10.1136/bmj.n104.
Authors
Gustavo C Machado
1
2
,
Christina Abdel-Shaheed
3
2
,
Martin Underwood
4
5
,
Richard O Day
6
7
Affiliations
1
Institute for Musculoskeletal Health, University of Sydney and Sydney Local Health District, Sydney, Australia gustavo.machado@sydney.edu.au.
2
Sydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
3
Institute for Musculoskeletal Health, University of Sydney and Sydney Local Health District, Sydney, Australia.
4
Warwick Clinical Trials Unit, University of Warwick, Coventry, UK.
5
University Hospitals Coventry and Warwickshire, Coventry, UK.
6
Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital, Sydney, Australia.
7
St Vincent's Clinical School, University of New South Wales, Sydney, Australia.
PMID:
33514562
DOI:
10.1136/bmj.n104
No abstract available
Publication types
Case Reports
Review
MeSH terms
Administration, Cutaneous
Administration, Oral
Aged
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Humans
Male
Musculoskeletal Pain / drug therapy*
Substances
Anti-Inflammatory Agents, Non-Steroidal